CSIMarket
 
Plx Pharma Inc   (NASDAQ: PLXP)
 

Plx Pharma Inc's Suppliers Performance

PLXP's Supply Chain




 
PLXP Costs vs Sales of Suppliers Growth Plx Pharma Inc's cost of sales deteriorated by -62.69 % year on year, sequentially cost of sales grew by 78.05 % in Q3.

More on PLXP Suppliers



Plx Pharma Inc's cost of sales deteriorated by -62.69 % year on year, sequentially cost of sales grew by 78.05 % in Q3.

More on PLXP Suppliers




Plx Pharma Inc's Comment on Supply Chain









PLXP's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Plx Pharma Inc 2.49 4.54 -25.37 -
SUBTOTAL 0.00 0.00 0.00 -


Sources: Plx Pharma Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Plx Pharma Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.